Fifth Third Bancorp Novartis Ag Transaction History

Fifth Third Bancorp

$25.9 Billion
Q1 2025

A detailed history of Fifth Third Bancorp transactions in Novartis Ag stock. As of the latest transaction made, Fifth Third Bancorp holds 23,925 shares of NVS stock, worth $2.77 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

23,925

Previous 44,342 46.04%

Holding current value

$2.77 Million

Previous $4.31 Million 38.18%

% of portfolio

0.01%

Previous 0.02%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 15, 2025	SELL	$97.14 - $115.57 $1.98 Million - $2.36 Million	-20,417 Reduced 46.04%	23,925 $2.67 Million
Q4 2024 Jan 21, 2025	SELL	$96.78 - $117.18 $286,372 - $346,735	-2,959 Reduced 6.26%	44,342 $4.31 Million
Q3 2024 Oct 17, 2024	BUY	$106.13 - $120.89 $24,940 - $28,409	235 Added 0.5%	47,301 $5.44 Million
Q2 2024 Jul 22, 2024	SELL	$92.57 - $107.37 $1.26 Million - $1.46 Million	-13,559 Reduced 22.37%	47,066 $5.01 Million
Q1 2024 Apr 23, 2024	BUY	$95.27 - $108.47 $141,952 - $161,620	1,490 Added 2.52%	60,625 $5.86 Million
Q4 2023 Jan 19, 2024	SELL	$92.27 - $101.54 $172,637 - $189,981	-1,871 Reduced 3.07%	59,135 $5.97 Million
Q3 2023 Oct 31, 2023	SELL	$94.73 - $105.13 $28,892 - $32,064	-305 Reduced 0.5%	61,006 $6.21 Million
Q2 2023 Jul 25, 2023	SELL	$92.52 - $104.91 $464,913 - $527,172	-5,025 Reduced 7.58%	61,311 $6.19 Million
Q1 2023 Apr 24, 2023	SELL	$80.03 - $92.81 $84,671 - $98,192	-1,058 Reduced 1.57%	66,336 $6.1 Million
Q4 2022 Jan 25, 2023	BUY	$75.55 - $92.52 $10,048 - $12,305	133 Added 0.2%	67,394 $0
Q3 2022 Oct 25, 2022	SELL	$74.61 - $87.26 $498,320 - $582,809	-6,679 Reduced 9.03%	67,261 $5.11 Million
Q2 2022 Aug 04, 2022	SELL	$80.52 - $93.75 $286,168 - $333,187	-3,554 Reduced 4.59%	73,940 $6.25 Million
Q1 2022 Apr 19, 2022	SELL	$80.11 - $90.62 $63,046 - $71,317	-787 Reduced 1.01%	77,494 $6.8 Million
Q4 2021 Feb 01, 2022	SELL	$79.7 - $88.13 $87,988 - $97,295	-1,104 Reduced 1.39%	78,281 $6.85 Million
Q3 2021 Oct 15, 2021	SELL	$81.78 - $95.14 $286,148 - $332,894	-3,499 Reduced 4.22%	79,385 $6.49 Million
Q2 2021 Aug 06, 2021	SELL	$85.24 - $94.15 $348,546 - $384,979	-4,089 Reduced 4.7%	82,884 $7.56 Million
Q1 2021 May 07, 2021	SELL	$83.5 - $98.47 $130,093 - $153,416	-1,558 Reduced 1.76%	86,973 $7.43 Million
Q4 2020 Feb 16, 2021	SELL	$78.07 - $94.43 $24,748 - $29,934	-317 Reduced 0.36%	88,531 $8.36 Million
Q3 2020 Nov 09, 2020	SELL	$82.14 - $91.0 $70,804 - $78,442	-862 Reduced 0.96%	88,848 $7.73 Million
Q2 2020 Aug 05, 2020	BUY	$80.93 - $91.1 $3,399 - $3,826	42 Added 0.05%	89,710 $7.84 Million
Q1 2020 May 05, 2020	SELL	$70.67 - $99.01 $8,692 - $12,178	-123 Reduced 0.14%	89,668 $7.39 Million
Q4 2019 Feb 14, 2020	SELL	$84.35 - $95.37 $42,765 - $48,352	-507 Reduced 0.56%	89,791 $8.5 Million
Q3 2019 Nov 14, 2019	SELL	$85.54 - $94.26 $302,554 - $333,397	-3,537 Reduced 3.77%	90,298 $7.85 Million
Q2 2019 Aug 07, 2019	SELL	$75.4 - $92.8 $491,306 - $604,684	-6,516 Reduced 6.49%	93,835 $8.57 Million
Q1 2019 May 14, 2019	SELL	$75.32 - $86.15 $164,348 - $187,979	-2,182 Reduced 2.13%	100,351 $9.65 Million
Q4 2018 Feb 14, 2019	SELL	$73.66 - $82.02 $375,518 - $418,137	-5,098 Reduced 4.74%	102,533 $8.8 Million
Q3 2018 Nov 14, 2018	SELL	$66.94 - $77.43 $1.27 Million - $1.47 Million	-19,037 Reduced 15.03%	107,631 $9.27 Million
Q2 2018 Aug 14, 2018	SELL	$64.91 - $73.36 $4.01 Million - $4.53 Million	-61,732 Reduced 32.77%	126,668 $9.57 Million
Q1 2018 May 15, 2018	SELL	$70.39 - $84.15 $481,960 - $576,175	-6,847 Reduced 3.51%	188,400 $15.2 Million
Q4 2017 Feb 14, 2018	SELL	$72.33 - $77.64 $328,450 - $352,563	-4,541 Reduced 2.27%	195,247 $16.4 Million
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $1.16 Million - $1.21 Million	15,598 Added 8.47%	199,788 $17.2 Million
Q2 2017 Aug 11, 2017	BUY	N/A	184,190	184,190 $15.4 Million

Others Institutions Holding NVS

# of Institutions

1,524

Shares Held

142M

Call Options Held

1.63M

Put Options Held

1.82M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $249B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Account

Fifth Third Bancorp Novartis Ag Transaction History